期刊文献+

程序化诊断治疗胃底巨大间质瘤一例

下载PDF
导出
摘要 患者女,53岁,因上腹部灼痛不适8个月,加重1个月门诊就诊,胃镜检查见:胃底穹窿部紧靠贲门见一直径约3 cm×4 cm大小隆起性改变,表面光滑、触之质硬,即以“胃底间质瘤?”收住入院进一步检查治疗。入院后体格检查:体温37.5℃、脉搏80次/min、心率18次/min、血压135/85 mm Hg(1 mm Hg=0.133 k Pa),全腹无阳性体征。
出处 《实用医技杂志》 2016年第6期623-623,共1页 Journal of Practical Medical Techniques
  • 相关文献

参考文献1

二级参考文献12

  • 1Rubin, Brian P,Blanke, Charles D,Demetri, George D,DeMatteo, Ronald P,Fletcher, Christopher D M,Goldblum, John R,Lasota, Jerzy,Lazar, Alexander,Maki, Robert G,Miettinen, Markku,Noffsinger, Amy,Washington, Mary Kay,Krausz, Thomas.Protocol for the Examination of Specimens From Patients With Gastrointestinal Stromal Tumor[J]. Archives of Pathology & Laboratory Medicine . 2010 (2)
  • 2Alberto S. Pappo,Katherine A. Janeway.Pediatric Gastrointestinal Stromal Tumors[J]. Hematology/Oncology Clinics of North America . 2009 (1)
  • 3George D Demetri,Allan T van Oosterom,Christopher R Garrett,Martin E Blackstein,Manisha H Shah,Jaap Verweij,Grant McArthur,Ian R Judson,Michael C Heinrich,Jeffrey A Morgan,Jayesh Desai,Christopher D Fletcher,Suzanne George,Carlo L Bello,Xin Huang,Charles M Baum,Paolo G Casali.Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial[J]. The Lancet . 2006 (9544)
  • 4Markku Miettinen,Jerzy Lasota.Gastrointestinal stromal tumors: Pathology and prognosis at different sites[J]. Seminars in Diagnostic Pathology . 2006 (2)
  • 5Martine Van Glabbeke.Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Meta-Analysis of 1,640 Patients. Journal of Clinical Oncology . 2010
  • 6Nilsson B,Bumming P,Meis-Kindblom JM,et al.Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer . 2005
  • 7Ohtani H,Maeda K,Noda E,et al.Meta-analysis of laparoscopic and open surgery for gastric gastrointestinal stromal tumor. Anticancer Research . 2013
  • 8Demetri GD,Reichardt P,Kang YK,Blay JY,Rutkowski P,Gelderblom H,Hohenberger P,Leahy M,von Mehren M,Joensuu H,Badalamenti G,Blackstein M,Le Cesne A,Sch ffski P,Maki RG,Bauer S,Nguyen BB,Xu J,Nishida T,Chung J,Kappeler C,Kuss I,Laurent D,Casali PG.Ef-ficacy and safety of regorafenib for advanced gastrointesti-nal stromal tumours after failure of imatinib and sunitinib (GRID):an international,multicentre,randomised,placebo-controlled,phase3trial. The Lancet . 2013
  • 9Kang TK,Ryu MH,Yoo C,et al.Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumors after failure of imatinib and sunitinib (RIGHT):a randomized,placebo-controlled,phase 3 trial. The Lancet Oncology . 2013
  • 10ESMO,European Sarcoma Network Working Group.Gastrointestinal stromal tumours:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up. Annals of Oncology . 2014

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部